Keyphrases
Junctional Adhesion Molecule
100%
Integrin β1
100%
Tissue Factor
100%
Self-renewal
100%
Glioblastoma
100%
Cancer Stem Cells
72%
Protease-activated Receptor 2 (PAR2)
33%
Receptor Tyrosine Kinase
22%
Integrin 1
16%
Specific Intent
16%
Stem Cell Subpopulation
11%
2 Receptor
11%
Stem Cell Activation
11%
Cell Adhesion
11%
Pro-tumor Activity
5%
SerpinB3
5%
Tumor Effect
5%
Serine Protease Inhibitor
5%
Pro-tumor
5%
Proliferative Effect
5%
In Vivo Growth
5%
2-complex
5%
Malignancy
5%
Hemostasis
5%
Stem Cell Survival
5%
G Protein-coupled Receptor
5%
Patient Outcomes
5%
Stem Cell Maintenance
5%
Tumor Recurrence
5%
Multiple Classes
5%
Adult Brain
5%
Poor Outcome
5%
Tumor Eradication
5%
Bleeding
5%
New Drug Targets
5%
Recurrent Tumor
5%
Stem Cell Expansion
5%
Cell Effects
5%
Common Cancers
5%
Glioblastoma Cells
5%
Transmembrane Protein
5%
Marker Expression
5%
Therapeutic Target
5%
Secreted Proteins
5%
Protective Effect
5%
Cytotoxic Therapy
5%
Therapeutic Relevance
5%
Blood Clot
5%
Medicine and Dentistry
Glioblastoma
100%
Thromboplastin
100%
Junctional Adhesion Molecule A
100%
Integrin
100%
Cancer Stem Cell
72%
Proteinase Activated Receptor 2
33%
Protein Tyrosine Kinase
22%
Neoplasm
16%
Tumor Recurrence
11%
Cell Subpopulation
11%
Malignant Neoplasm
11%
Serine Proteinase Inhibitor
11%
Kinase Signaling
11%
Cell Adhesion
11%
Drive
5%
Bleeding
5%
Blood Clotting
5%
Cell Function
5%
Cancer
5%
Cell Activity
5%
Epidermal Growth Factor Receptor
5%
Cell Survival
5%
Blood Stasis
5%
G Protein Coupled Receptor
5%
Cytotoxic Chemotherapy
5%
Neuroscience
Junctional Adhesion Molecule A
100%
Integrin
100%
Thromboplastin
100%
Cancer Stem Cell
72%
Protease-Activated Receptor 2
33%
Receptor Tyrosine Kinase
22%
In Vivo
11%
Cell Adhesion
11%
Cell Activity
5%
Serine Protease Inhibitor
5%
G Protein Coupled Receptor
5%
Hemostasis
5%
Cell Function
5%
Coagulation System
5%
Serpin
5%
Cell Survival
5%
Epidermal Growth Factor Receptor
5%